Coprevalence of COVID-19 and Dengue fever in Pakistan: Co-revalence of COVID-19 and Dengue fever in Pakistan

Usra Naeem; Babar  Mujtaba; Atif  Ikram; Manzoor Ahmad  Naeem; Syeda Asfara  Badar; Aisha  Naeem

doi:10.54393/pbmj.v5i1.270

Authors

Usra Naeem Department of Health Professional Technology, University of Lahore, Pakistan
Babar Mujtaba Department of Civil Engineering, Faculty of Sciences and Technology, University of Coimbra, Rua Luís Reis Santos, Pólo II - Universidade de Coimbra, 3030-788 Coimbra, Portugal
Atif Ikram Department of Rehabilitation Sciences, University of Lahore, Pakistan
Manzoor Ahmad Naeem Diaverum Institute of Dialysis 9011 Mecca, Kingdom of Saudi Arabia
Syeda Asfara Badar Department of Health Professional Technology, University of Lahore, Pakistan
Aisha Naeem Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC

DOI:

https://doi.org/10.54393/pbmj.v5i1.270

Keywords:

Dengue fever, COVID-19, Dengue in Pakistan, Dengue and COVID-19 coinfection, coprevalence of COVID and Dengue

Abstract

Pakistan is facing an epidemic of dengue fever amidst COVID-19 outbreak which is a serious public health concern. This article provides an overview of factors that could have led to an unexpectedly higher number of Dengue fever cases in Pakistan this year, such as, insufficient preventive measures to control Dengue at the national and domestic level, lack of surveillance system for the spread and control of the disease, and the lack of awareness among the general population regarding the possible outbreak of the disease. This situation has challenged the overburdened healthcare system of the developing country, which was still recovering from the immense pressure of COVID-19. This study also highlights the challenges faced by physicians regarding the diagnosis and treatment of patients who are coinfected with COVID-19 and Dengue fever. Early detection and accurate diagnosis are crucial for the management of patients with either of the disease. Authors have suggested a few measures that may help in improving the management and prognosis of patients coinfected with COVID-19 and Dengue fever. Additionally, we have also proposed a few strategies, that, if adapted at the national level may help in controlling the spread of Dengue fever in the future. For example, policies should be devised by the government for the implementation of preventive measures at the domestic level which was in practice before the outbreak of COVID-19.

References

World Health Organization, 2021. Dengue fever. Available from: http://www.emro.who.int/pak/programmes/dengue-fever.html

Outbreak News Today, 2021. Available from:

http://outbreaknewstoday.com/pakistan-dengue-tally-tops-25000/

World Health Organization, 2021. WHO support to Pakistan on dengue fever. Available from: http://www.emro.who.int/pak/pakistan-infocus/world-health-day.html

National Institute of Health, 2021. Seasonal awareness and alert letter. Available from: https://www.nih.org.pk/wp-content/uploads/2021/10/52nd-Issue-SAAL-print-version-11-OCTOBER-2021.pdf

World Health Organization, 2021. Weekly epidemiological update on COVID-19-9-November 2021. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---9-november-2021

National Information Technology Board, Government of Pakistan, 2021. Available from: https://covid.gov.pk/stats/pakistan

Coronavirus (COVID-19) vaccination, 2021. Available from: https://ourworldindata.org/covid-vaccinations

Pakistan Bureau of Statistics, 2020. Special survey for evaluating the socio-economic impact of COVID-19 on well-being of people. Available from: https://www.pbs.gov.pk/sites/default/files//other/covid/key_findings_presentation_covid_survey.pdf

Mohamud MA, Qazi U, Latif A, Khan IU, Anwar S. Dengue outbreak response and control in Khyber Pakhtunkhwa, Pakistan: A mixed methods study. J Epidemiol Glob Health. 2020;10:74-81.

https://doi.org/10.2991/jegh.k.191125.001

Niazkar HR, Zibaee B, Nasimi A, Bahri N. The neurological manifestations of COVID-19: a review article. Neurol Sci. 2020; 41:1667-1671.

https://doi.org/10.1007/s10072-020-04486-3

Effler PV, Pang L, Kitsutani P, Vorndam V, Nakata M, Ayers T, et al. Dengue fever, Hawaii, 2001-2002. Emerg Infect Dis. 2005; 11:742-749.

https://doi.org/10.3201/eid1105.041063

Haddock E, Feldmann F, Shupert WL, Feldmann H. Inactivation of SARS-CoV-2 laboratory specimens. Am J Trop Med Hyg. 2021;104:2195-2198.

https://doi.org/10.4269/ajtmh.21-0229

Mohan A, Fakhor H, Nimavat N, Wara UU, Lal PM, dos Santos Costa AC, et al. Dengue and COVID‐19: A risk of coepidemic in Ethiopia. J Med Virol. 2021; 93:5680-5681.

https://doi.org/10.1002/jmv.27116

Saddique A, Rana MS, Alam MM, Ikram A, Usman M, Salman M, et al. Emergence of co-infection of COVID-19 and dengue: A serious public health threat. J Infect. 2020; 81:16-18.

https://doi.org/10.1016/j.jinf.2020.08.009

Mohan A, Fakhor H, Nimavat N, Wara UU, Lal PM, Costa ACDS, et al. Dengue and COVID-19: A risk of coepidemic in Ethiopia. J Med Virol. 2021; 93:5680-5681.

https://doi.org/10.1002/jmv.27116

Masyeni S, Santoso MS, Widyaningsih PD, Asmara DW, Nainu F, Harapan H, et al. Serological cross-reaction and coinfection of dengue and COVID-19 in Asia: Experience from Indonesia. Int J Infect Dis. 2021; 102:152-154.

https://doi.org/10.1016/j.ijid.2020.10.043

Lustig Y, Keler S, Kolodny R, Ben-Tal N, Atias-Varon D, Shlush E, et al. Potential antigenic cross-reactivity between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Dengue Viruses. Clin Infect Dis. 2021; 73:2444-2449.

https://doi.org/10.1093/cid/ciaa1207